/ /

  • linkedin
  • Increase Font
  • Sharebar

    Surgical management of endometriosis associated infertility: Time for a paradigm change

     

     

    Laurie J. McKenzie is Director of Oncofertility at Houston IVF and Director of Houston Oncofertility Preservation and Education (H.O.P.E.), Texas. She is also a member of the Contemporary OB/GYN editorial board.

     

    Endometriosis is one of the most challenging clinical entities for gynecologists. The resultant pain and infertility are often difficult to manage, and strategies are limited. I propose a more cautious approach to endometriosis-associated infertility, based on emerging evidence that “less is more” in surgical management of this problem.

    A recent case highlights the clinical issues.

    Case

    J.E. is a 34-year-old P0 who initially presented in January 2014 after attempting pregnancy for 2 years. She reported a diagnosis of endometriosis as well as male-factor infertility. Her endometriosis was diagnosed via laparoscopy in December 2013 and her initial surgery was ablation of visible implants plus resection of a 4-cm endometrioma.

    Prior fertility testing included a hysterosalpingogram obtained in November 2013, which demonstrated an occluded left Fallopian tube and an anti-Müllerian hormone (AMH) level that was reassuring at 1.6 ng per mL. Partner history was significant for a semen analysis that demonstrated 6 million sperm with 10% motility.

    At J.E.’s initial infertility evaluation, a transvaginal ultrasound demonstrated suspected bilateral recurrent endometriomas measuring 5 and 10 cm. We discussed management options, including proceeding directly to in vitro fertilization (IVF) versus resection of the endometriomas. She was asymptomatic, but given the size of the endometriomas, I recommended repeat laparoscopy and resection of the endometriomas.

    Four months postoperative, J.E.’s AMH was undetectable. Six months postoperative, she underwent an IVF. Despite an aggressive 16-day stimulation, no oocytes were recovered. Her AMH remains undetectable. She is now considering use of donor oocytes.

    See also: Could severe teen acne signal risk of endometriosis?

     

    Laurie J McKenzie, MD
    Dr. McKenzie is Director of Oncofertility, Houston IVF, and Director, Houston Oncofertility Preservation and Education (H.O.P.E.), ...

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    Latest Tweets Follow